# Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection

> **NCT04493918** · PHASE2 · UNKNOWN · sponsor: **Ahmad Jabir Rahyussalim** · enrollment: 20 (estimated)

## Conditions studied

- Spinal Tuberculosis
- Mesenchymal Stem Cell

## Interventions

- **COMBINATION_PRODUCT:** Mesenchymal Stem cell + Nacl 0.9%
- **COMBINATION_PRODUCT:** NaCl 0.9%

## Key facts

- **NCT ID:** NCT04493918
- **Lead sponsor:** Ahmad Jabir Rahyussalim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-21
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04493918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04493918, "Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04493918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*